The patient pathway

Medicinal cannabis in New Zealand is a regulated pharmaceutical pathway under the Misuse of Drugs Act 1975, not a general licence to use cannabis. Since the Medicinal Cannabis Scheme came into effect in April 2020, the Ministry of Health has overseen a framework where medicines must meet Good Manufacturing Practice (GMP) standards and be approved by Medsafe before they can be prescribed. The thing newcomers most often get wrong is that “legal medicinal cannabis” does not mean a patient can legally smoke raw plant material or buy unregulated preparations. The legal form is a manufactured medicine, and the raw flower, while available, is prescribed and dispensed through a pharmacy, not a dispensary.

The one question this overview answers: What is the regulated patient pathway for medicinal cannabis in New Zealand, and what are the main choices and legal boundaries along it? This is not a clinical guide, a preparation review or a promise of access. It describes the regulated route from a doctor’s consultation to a pharmacy-dispensed medicine, and it points to four focused guides where you can go deeper.

What medicinal cannabis is and is not) in New Zealand

Medicinal cannabis is a prescription medicine. It is not a general licence to use cannabis, and it is not the same as raw plant material people may associate with recreational use. Under the Misuse of Drugs Act 1975, the Medicinal Cannabis Scheme (established by the Misuse of Drugs (Medicinal Cannabis) Regulations 2019) legalises access to cannabis-based preparations when a medical practitioner prescribes them. The scheme is administered by the Medicinal Cannabis Agency (MCA), which sits within Medsafe, the country’s medicines regulator (Medsafe, 2020).

The key boundary: a prescription from a doctor is required. The scheme does not create a “green light” for general use. Preparations must meet GMP standards and be approved by the Ministry of Health. This means the legal item is a manufactured medicine, not raw plant material bought from an unregulated source. Even the raw flower, when prescribed, is dispensed through a pharmacy, not a dispensary.

What the scheme does not do: It does not legalise recreational use, it does not allow self-medication with street cannabis, and it does not permit a doctor to write a prescription for a preparation that has not been approved under the scheme. The Misuse of Drugs Act remains the legal boundary, and the Medicinal Cannabis Scheme is the only lawful route to access.

How the scheme operates

The scheme, established under the Misuse of Drugs (Medicinal Cannabis) Regulations 2019, legalises the cultivation, manufacture, supply and possession of medicinal cannabis preparations that meet GMP standards and are approved by the Ministry of Health. The preparations are manufactured medicines, not raw plant material sold as a “natural” remedy. While dried flower is available, it is prescribed and dispensed through a pharmacy, not a dispensary. The MCA, part of Medsafe, administers the scheme.

The legal frame: a medical practitioner can prescribe, a pharmacist can dispense, and the patient can possess and use the preparation as directed. Possession outside that prescription remains illegal. The Misuse of Drugs Act 1975 (as amended by the Misuse of Drugs (Medicinal Cannabis) Amendment Act 2018) sets this frame, and the Medicinal Cannabis Scheme provides the only legal route for patients.

What counts as a medicinal cannabis preparation

Medicinal cannabis is not a single plant or preparation. Under the scheme, a medical practitioner can prescribe a cannabis-based medicine for a patient. The medicine must meet GMP standards and be approved by the Ministry of Health. Even when the preparation is dried flower, it is prescribed and dispensed through a pharmacy, not a dispensary, and the patient must follow the prescription exactly. There is no general licence to possess or use cannabis for medical purposes outside this pathway.

The common misunderstanding is that “legal medicinal cannabis” means a patient can legally smoke raw plant material or buy unregulated items. That is not the case. The legal form is a manufactured medicine. Raw flower is available, but it is prescribed and dispensed through a pharmacy, not a dispensary. Preparations that are not part of this scheme remain illegal, regardless of how they are marketed.

Starting the process

If you are trying to make sense of how medicinal cannabis actually works in New Zealand, you may be a patient, a whānau member, a clinician or someone researching the system. The overview gives you the map. It explains the legal route, the main choices you will meet and where to go next. It does not recommend any preparation, dose or prescriber.

The four focused guides own the detail; this overview owns the map. After reading it, you will know how the Medicinal Cannabis Scheme works, what a prescription involves, how CBD and THC differ, and what questions to take to a clinician.

What the pathway does not do

The pathway does not tell you which preparation is “best” or whether cannabis will help your condition; those decisions belong to your prescriber and to the focused guides. It tells you how the pathway works, who is involved and where to go next. It does not diagnose, prescribe or promise access.

Caution and driving

Medicinal cannabis can cause drowsiness, dizziness and impaired concentration. Do not drive or operate heavy machinery until you know how your prescribed medicine affects you. Driving while impaired is a criminal offence under the Land Transport Act 1998, regardless of whether the medicine was prescribed. Discuss impairment risk with your prescriber before starting treatment.

Where to go next

The four focused guides cover each stage in depth: finding a prescriber, understanding CBD and THC, navigating pharmacy dispensing and managing cost. Use the overview to orient yourself, then move to the guide that matches your next decision.